Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers

Vaccine

Volumn 23, Issue 29, 2005, Pages 3829-3835

  Southern, Jo ^a   Andrews, Nick ^a   Burrage, Moya ^a   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Booster; TdaP; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFECT; ERYTHEMA; FAINTNESS; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE REACTION; MALAISE; MALE; NAUSEA AND VOMITING; NORMAL HUMAN; PAIN; PERTUSSIS; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ANTIGENS, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; GREAT BRITAIN; HUMANS; IMMUNIZATION, SECONDARY; MALE; POLIOVIRUS VACCINE, INACTIVATED; SINGLE-BLIND METHOD;

EID: 18944371591     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.030     Document Type: Article

References (26)

1. E. Elliott, P. McIntyre, G. Ridley, A. Morris, J. Massie, and J. McEniery National study of infants hospitalized with pertussis in the acellular vaccine era Pediatr Infect Dis J 23 3 2004 246 252
2. C. Couzigou, and A. Flahault Is pertussis being considered as a cause of persistent cough among adults? Eur J Epidemiol 18 10 2003 1013 1015
3. W.A. Orenstein Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination Clin Infect Dis 28 Suppl. 2 1999 147 150
4. Miller E, Fleming D, Ashworth EA, Mabbett DA, Vurdien JE, Elliott TS. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health 2000;3(2):132-4. Erratum in: Commun Dis Public Health 2000;3(3):221
5. K.M. Bisgard, F.B. Pascual, K.R. Ehresmann, C.A. Miller, C. Cianfrini, and C.E. Jennings Infant pertussis: who was the source? Pediatr Infect Dis J 23 11 2004 985 989
6. J.D. Cherry Epidemiological, clinical, and laboratory aspects of pertussis in adults Clin Infect Dis 28 Suppl. 2 1999 S112 S117
7. D. Jenkinson Natural course of 500 consecutive cases of whooping cough: a general practice population study BMJ 310 6975 1995 299 302
8. N.S. Crowcroft, R. Booy, T. Harrison, L. Spicer, J. Britto, and Q. Mok Severe and unrecognised: pertussis in UK infants Arch Dis Child 88 9 2003 802 806
9. E. Miller, M. Rush, Ashworth LAE, T.J. Coleman, J. Rossini, and O.A. Ahmed Antibody responses and reactions to the whole cell component of a combined diphtheria/tetanus/pertussis vaccine given at school entry Vaccine 13 1995 1183 1186
10. K.M. Edwards, M.D. Decker, B.S. Graham, J. Mezzatesta, J. Scott, and J. Hackell Adult immunisation with acellular pertussis vaccine JAMA 269 1993 53 56
11. E.P. Rothstein, E.L. Anderson, M.D. Decker, G.A. Poland, K.S. Reisinger, and M.M. Blatter An acellular pertussis vaccine in healthy adults: safety and immunogenicity Vaccine 17 1999 2999 3006
12. Keitel WA, Muenz LR, Decker DD, Englund JA, Mink CM, Blumberg DA et al. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparison of 5 vaccines and implications for booster immunization. JID 1999;180:397-403
13. O. Ruuskanen, A. Noel, A. Putto-Laurila, J. Petre, C. Capiau, and A. Delem Development of an acellular pertussis vaccine and its administration as a booster in healthy adults Vaccine 9 1991 117 121
14. D. Salisbury N.T. Begg Immunisation Against Infectious Disease 1996 HMSO Department of Health, UK
15. M.G. Thomas, L.A. Ashworth, E. Miller, and H.P. Lambert Serum IgG IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine J. Infect. Dis. 160 1989 838 845
16. E. Miller, Ashworth LAE, K. Redhead, C. Thornton, P.A. Waight, and T. Coleman Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance Vaccine 15 1997 51 60
17. E. Miller, D. Salisbury, and M. Ramsay Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story Vaccine 20 2002 S58 S67
18. M. Burrage, A. Robinson, R. Borrow, N. Andrews, J. Southern, and J. Findlow Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection Infect Immun 70 2002 4946 4954
19. M. Van der Wielen, P. Van Damme, E. Joossens, G. Francois, F. Meurice, and A. Ramalho A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTap) vaccine in adults Vaccine 18 20 2000 2075 2082
20. S.A. Halperin, B. Smith, M. Russell, D. Scheifele, E. Mills, and P. Hassleback Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults Pediatr Infect Dis J 19 4 2000 276 283
21. A. Nardone, R.G. Pebody, Maple PAC, N. Andrews, N.J. Gay, and E. Miller Sero-epidemiology of Bordetella pertussis in England and Wales Vaccine 22 2004 1314 1319
22. D. Jenkinson Duration of effectiveness of pertussis vaccines: evidence from a 10 year community study BMJ 296 1988 612 614
23. M.E.B. Ramsay, C.P. Farrington, and E. Miller Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic period Epidemiol Infect 111 1993 41 48
24. N.S. Crowcroft, and J. Britto Whooping cough-a continuing problem, pertussis has re-emerged in countries with high vaccination coverage and low mortality BMJ 324 2002 1537 1538
25. E. Miller Overview of recent clinical trials of acellular pertussis vaccines Biologicals 27 1999 79 86
26. D.W. Scheifele, S. Dobson, A. Kallos, G. Bjornson, and J.J. Ochnio Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9 Pediatr Infect Dis J 17 1998 1121 1126